Primrose Bio® Raises Significant Growth Capital Investment Led by Signet Healthcare Partners
PR Newswire•22/09/2026•09:00 ET
0
Primrose Bio® Raises Significant Growth Capital Investment Led by Signet Healthcare Partners PR Newswire
SAN DIEGO, Sept. 22, 2026 /PRNewswire/ -- Primrose Bio, Inc. ("Primrose"), a provider of production solutions for next-generation biologics, today announced the closing of a financing round led by new investor Signet Healthcare Partners ("Signet"), with significant participation from existing investors 1315 Capital, Ligand Pharmaceuticals Incorporated (Nasdaq: LGND), LDV Partners, and Agent Capital. In conjunction with the financing, James Gale, Founding Partner and Managing Director of Signet, has joined Primrose's Board of Directors.
Get started
Create a free account to read the full story and Whiz Insights.